Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Tak

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Arthritis and Rheumatism|April 1, 2011
Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: a case series and cohort studyL A Korswagen, G M Bartelds, C L M Krieckaert, et al.
Annals of the Rheumatic Diseases|January 16, 2007
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patientsT C T M van der Pouw Kraan, C A Wijbrandts, L G M van Baarsen, et al.
Annals of the Rheumatic Diseases|April 14, 2009
Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort studyW H Bos, G J Wolbink, M Boers, et al.
Annals of the Rheumatic Diseases|September 16, 2011
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept studyM J H Boumans, J G A Houbiers, P Verschueren, et al.
Annals of the Rheumatic Diseases|December 24, 2010
Different stages of rheumatoid arthritis: features of the synovium in the preclinical phaseM G H van de Sande, M J H de Hair, C van der Leij, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritisM J H de Hair, M G H van de Sande, T H Ramwadhdoebe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2014
Reply: To PMID 24574210M J H de Hair, M G H van de Sande, T H Ramwadhdoebe, et al.
Annals of the Rheumatic Diseases|April 5, 2008
The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levelsW H Bos, J Ursum, N de Vries, et al.
Annals of the Rheumatic Diseases|June 18, 2014
Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritisD E A Greven, E S Cohen, D M Gerlag, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune diseaseP L Klarenbeek, M J H de Hair, M E Doorenspleet, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Arthritis and Rheumatism|April 1, 2011
Venous and arterial thromboembolic events in adalimumab-treated patients with antiadalimumab antibodies: a case series and cohort studyL A Korswagen, G M Bartelds, C L M Krieckaert, et al.
Annals of the Rheumatic Diseases|January 16, 2007
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patientsT C T M van der Pouw Kraan, C A Wijbrandts, L G M van Baarsen, et al.
Annals of the Rheumatic Diseases|April 14, 2009
Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort studyW H Bos, G J Wolbink, M Boers, et al.
Annals of the Rheumatic Diseases|September 16, 2011
Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept studyM J H Boumans, J G A Houbiers, P Verschueren, et al.
Annals of the Rheumatic Diseases|December 24, 2010
Different stages of rheumatoid arthritis: features of the synovium in the preclinical phaseM G H van de Sande, M J H de Hair, C van der Leij, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritisM J H de Hair, M G H van de Sande, T H Ramwadhdoebe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2014
Reply: To PMID 24574210M J H de Hair, M G H van de Sande, T H Ramwadhdoebe, et al.
Annals of the Rheumatic Diseases|April 5, 2008
The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levelsW H Bos, J Ursum, N de Vries, et al.
Annals of the Rheumatic Diseases|June 18, 2014
Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritisD E A Greven, E S Cohen, D M Gerlag, et al.
Annals of the Rheumatic Diseases|February 2, 2012
Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune diseaseP L Klarenbeek, M J H de Hair, M E Doorenspleet, et al.
Pageof 21